尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Feldmann Marc, 董事. Director active across 1 company, notably 180 Life Sciences Corp.. Cumulatively, 4 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €4k. History available since 30 September 2021. The latest transaction was disclosed on 28 December 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Marc Feldmann is a Board Member at 180 Life Sciences Corp. He brings his expertise in corporate governance and strategy, participating in the oversight of operations and strategic decision-making within the organization.